市場調查報告書
商品編碼
1291352
一次性使用生物反應器市場:2023-2028年全球行業趨勢、佔有率、規模、成長、機會和預測Single-Use Bioreactors Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 |
全球一次性生物反應器市場規模在2022年達到29億美元。展望未來,IMARC Group預計,到2028年,市場規模將達到72億美元,在2023-2028年期間呈現15.3%的成長率(CAGR)。
一次性使用生物反應器(SUB),也被稱為一次性生物反應器,依靠一個一次性袋子,而不是使用不銹鋼或玻璃製成的培養容器。它使用和安裝靈活方便,所需的公用設施也較少,包括蒸汽和水。除此之外,它還能降低勞動成本,將交叉污染的風險降到最低,並消除了清潔過程和驗證問題。因此,它在全世界的契約研究組織(CRO)和契約製造組織(CMO)中得到了廣泛的應用。
一次性使用生物反應器被用於製藥行業的培養基和緩衝液製備、細胞採集、過濾、純化和病毒去活化。它們也被用於學術和商業規模的實驗室,用於藥物發現、生物燃料製造以及疫苗和抗體的開發。這與蓬勃發展的生物製藥業相結合,是推動市場成長的關鍵因素之一。此外,對傳統生物反應器進行高壓滅菌可能成為一個漫長、昂貴和不穩定的製藥過程。然而,SUBs利用預消毒的生物工藝袋,因此減少了額外的成本和消毒時間。除此之外,由於它們比傳統的生物反應器有更少的活動部件,SUBs的維護成本更低。除此之外,與不銹鋼設備相比,SUBs對環境的總體影響較小。這一點,再加上世界各地越來越多的臨床試驗,正在催化它們在全球的需求。此外,領先的企業越來越重視產品創新和併購(M&A),以擴大他們的客戶群和增加他們的地理分佈。這一點,加上對一次性使用技術(SUT)的不斷採用,正在增強整體銷售和盈利能力。
The global single-use bioreactors market size reached US$ 2.9 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 7.2 Billion by 2028, exhibiting a growth rate (CAGR) of 15.3% during 2023-2028.
A single-use bioreactor (SUB), also known as a disposable bioreactor, relies on a disposable bag instead of a culture vessel made using stainless steel or glass. It is flexible and easy to use and install, and requires fewer utility requirements, including steam and water. Besides this, it reduces labor costs, minimizes the risk of cross-contamination, and eliminates the cleaning process and validation issue. As a result, it finds extensive applications in contract research organizations (CROs) and contract manufacturing organizations (CMOs) worldwide.
SUBs are employed in the pharmaceutical industry for media and buffer preparation, cell harvesting, filtration, purification, and virus inactivation. They are also used in academic and commercial-scale laboratories for drug discovery, biofuel manufacturing, and the development of vaccines and antibodies. This, in confluence with the burgeoning biopharmaceutical industry, represents one of the key factors impelling the growth of the market. Moreover, autoclaving a conventional bioreactor can become a lengthy, costly, and inconsistent pharmaceutical manufacturing process. However, SUBs utilize presterilized bioprocess bags and consequently reduce the additional costs and time of sterilization. Besides this, as they have fewer moving parts than conventional bioreactors, SUBs are less expensive to maintain. Apart from this, SUBs have a lower overall impact on the environment compared to stainless steel equipment. This, coupled with the growing number of clinical trials around the world, is catalyzing their demand across the globe. Furthermore, leading players are increasingly focusing on product innovations and mergers and acquisitions (M&A) to expand their customer base and increase their geographical presence. This, along with the rising adoption of single-use technology (SUT), is augmenting the overall sales and profitability.
IMARC Group provides an analysis of the key trends in each sub-segment of the global single-use bioreactors market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product type, type, cell type, molecule type and end user.
Single-use Bioreactor Systems
Media Bags
Filtration Assemblies
Others
Stirred-tank Bioreactors
Wave-induced Bioreactors
Bubble-column Bioreactors
Others
Mammalian Cell
Bacteria
Yeast
Others
Vaccines
Monoclonal Antibodies
Stem Cells
Recombinant Proteins
Others
Pharmaceutical and Biopharmaceutical Companies
Contract Research Organizations
Academic and Research Institutes
Others
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being ABEC Inc., Cellexus, Celltainer Biotech B.V., CESCO Bioengineering Co. Ltd., Distek Inc., Eppendorf SE, General Electric Company, Getinge AB, Merck KGaA, Pall Corporation (Danaher Corporation), PBS Biotech Inc., Sartorius AG and Thermo Fisher Scientific Inc.
Key Questions Answered in This Report
1. What was the size of the global single-use bioreactors market in 2022?
2. What is the expected growth rate of the global single-use bioreactors market during 2023-2028?
3. What are the key factors driving the global single-use bioreactors market?
4. What has been the impact of COVID-19 on the global single-use bioreactors market?
5. What is the breakup of the global single-use bioreactors market based on the product type?
6. What is the breakup of the global single-use bioreactors market based on the type?
7. What is the breakup of the global single-use bioreactors market based on the cell type?
8. What is the breakup of the global single-use bioreactors market based on the molecule type?
9. What are the key regions in the global single-use bioreactors market?
10. Who are the key players/companies in the global single-use bioreactors market?
Figure 98 Middle East and Africa: Single-use Bioreactor Market: Sales Value (in Million US$), 2017 & 2022